State Of Wisconsin Investment Board Eq Rx, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $1,688 - $2,349	1,017 Added 0.82%	124,595 $276,000
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $1,787 - $2,175	-1,110 Reduced 0.89%	123,578 $229,000
Q1 2023 May 15, 2023	SELL	$1.8 - $2.83 $24,957 - $39,237	-13,865 Reduced 10.01%	124,688 $241,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $18,482 - $49,588	-9,016 Reduced 6.11%	138,553 $340,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $7,539 - $48,045	-8,021 Reduced 5.16%	147,569 $730,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $497,888 - $885,307	155,590 New	155,590 $730,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.